Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2013 Jul 5;22(9):1520–1528. doi: 10.1158/1055-9965.EPI-13-0345

Table 3.

Odds ratios (OR) and 95% confidence intervals (CI) for prostate cancer associated with single nucleotide variants in BTNL2 in European Americans

Cases (n = 1,155) Controls (n = 1,060)
Genotype n % n % ORa 95% CI P-value
rs41441651
    CC 1,129 (97.8) 1,051 (99.2) 1.00 –
    CT or TTb 26 (2.3) 9 (0.9) 2.73 (1.27–5.87) 0.010
rs28362675
    CC 1,131 (97.9) 1,051 (99.2) 1.00 –
    CA or AAb 24 (2.1) 9 (0.9) 2.52 (1.16–5.46) 0.019
a

Adjusted for age.

b

One case is homozygous variant for both SNVs; 22 cases and 9 controls are heterozygous for both SNVs.